Evidence map›Paper›PMID 26115221›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Novel mechanism of transcriptional regulation of cell matrix protein through CREB.

Samy L Habib, Sumathy Mohan, Sitai Liang, Baojie Li, Mukesh Yadav

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. TP63 Is Significantly Upregulated in Diabetic Kidney.International journal of molecular sciences · 2021
    Article
  7. What turns CREB on? And off? And why does it matter?Cellular and molecular life sciences : CMLS · 2020
    Review
  8. Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Samy L Habiba South Texas Veterans Health Care System ; San Antonio , TX USA.
Sumathy Mohan
Sitai Liang
Baojie Li
Mukesh Yadav
Shanghai Jiao Tong University · CNSouth Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · US

Funding

Role of Diabetes in Development of Renal Cell CarcinomaI01BX000924 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI HABIB, SAMY LEWIZ · 2011 to 2017
–
BLRD VA I01 BX000924
6 · The paper itself

Abstract

The transcription mechanism(s) of renal cell matrix accumulation in diabetes does not explored. Phosphorylation of the transcription factor cAMP-responsive element binding protein (CREB) significantly increased in cells treated with high glucose (HG) compared to cell grown in normal glucose (NG). Cells pretreated with rapamycin before exposure to HG showed significant decrease phosphorylation of CREB, increase in AMPK activity and decrease protein/mRNA and promoter activity of fibronectin. In addition, cells transfected with siRNA against CREB showed significant increase in AMPK activity, decrease in protein/mRNA and promoter activity of fibronectin. Cells treated with HG showed nuclear localization of p-CREB while pretreated cells with rapamycin reversed HG effect. Moreover, gel shift analysis shows increase binding of CREB to fibronectin promoter in cells treated with HG while cells pretreated with rapamycin reversed the effect of HG. Furthermore, db/db mice treated with rapamycin showed significant increase in AMPK activity, decrease in expression of p-CREB and protein/mRNA of fibronectin. Strong staining of fibronectin and p-CREB was detected in kidney cortex of db/db mice while treated mice with rapamycin reversed hyperglycemia effect. In summary, our data provide a novel mechanism of transcriptional regulation of fibronectin through CREB that may be used as therapeutic approach to prevent diabetes complications.

Indexed as

Transcription, GeneticAdenylate KinaseAnimalsBase SequenceBinding SitesCyclic AMP Response Element-Binding ProteinDiabetes MellitusFibronectinsGene Expression RegulationHEK293 CellsHumansKidneyMaleMice, ObesePhosphorylationPromoter Regions, GeneticAdenylate KinaseCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinFibronectinsAMPKcell matrixCREBfibronectinrenal cellstranscription

Identifiers

PMID26115221
PMCPMC4613654
OpenAlexW1587649496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.